Second Hospital Of Shanxi Medical University

This study tests whether adding the drug tislelizumab to standard chemotherapy and chest radiation can help people with extensive-stage small-cell lung cancer live longer without their disease getting worse. About 40 adults aged 18-80 who have not had prior treatment for this sta…